The short version of somatotroph fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-08-27 and is reviewed periodically as new material appears.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
Binding of tesamorelin to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and the release of growth hormone into circulation. Because the peptide acts upstream of the growth hormone axis, its effects are partly mediated by hepatic insulin-like growth factor 1 (IGF-1) production. The pulsatile character of endogenous growth hormone secretion is preserved rather than replaced. Whether amplified signaling produces effects beyond those of native GHRH remains an area of ongoing investigation.
Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.
Physicochemical behavior is dominated by the peptide backbone. The molecule is hydrophilic and carries a net positive charge near neutral pH, owing to several arginine and lysine residues. In solution it adopts a largely unstructured conformation, and aggregation is a known concern for peptide products of this size. Oxidation of methionine and deamidation of asparagine or glutamine residues are the principal chemical degradation routes. These liabilities shape how the material is formulated, handled, and analyzed, and they explain why lyophilized presentations are common in research settings.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | GHRH receptor agonist |
| Residue count | 44 amino acids | N-terminal trans-3-hexenoyl group |
| Approximate mass | About 5.1 kDa | Derived from the peptide sequence |
| Primary target | Pituitary GHRH receptor | Somatotroph cells of the anterior pituitary |
| Downstream marker | IGF-1 | Measured indirectly in circulation |
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
Sanyaa – a type of dried fish prepared by the Newars. Dried shrimp – shrimp that have been sun-dried and shrunk. They are used in many Asian cuisines, imparting a unique umami taste. Shũṭki (শুঁটকি) or Shũṭki machh (শুঁটকি মাছ) – sun-dried fish or shrimp as prepared in Bengali and Assamese cuisine in India and Bangladeshi cuisine in general. In Western India it's colloquially called Bombay Duck. Dried fish is also used in some parts of South India and Sri Lanka Dried shredded squid – a dried, seasoned, seafood product, made from squid or cuttlefish, commonly found in coastal Asian countries, Russia, and Hawaii. Stockfish – unsalted fish, especially cod, dried by cold air and wind on wooden racks on the foreshore, called "hjell".
== Bibliography == Malegapuru William Makgoba, ed., African Renaissance, Mafube and Tafelberg, Sandton and Cape Town, 1999 Okumu, Washington A. J. (2002). The African Renaissance. Trenton, NJ and Asmara, Eritrea: Africa World Press. ISBN 1-59221-012-0.
primase Any of a class of enzymes that catalyze the synthesis of short, ~10-base RNA oligonucleotides, which by complementing the lagging strand during DNA replication are used as primers by DNA polymerase to initiate the synthesis of Okazaki fragments.
== History == The MHD description of electrically conducting fluids was first developed by Hannes Alfvén in a 1942 paper published in Nature titled "Existence of Electromagnetic–Hydrodynamic Waves", which outlined his discovery of what are now known as Alfvén waves. Alfvén initially referred to these waves as "electromagnetic–hydrodynamic waves"; however, in a later paper, he noted, "As the term 'electromagnetic–hydrodynamic waves' is somewhat complicated, it may be convenient to call this phenomenon 'magneto–hydrodynamic' waves."
Sources: en.wikipedia.org
Seaborg's discovery that the actinides were in fact f-block rather than d-block elements. The periodic table and law have become a central and indispensable part of modern chemistry. The periodic table continues to evolve with the progress of science. In nature, only elements up to atomic number 94 exist; elements beyond that are synthetic elements that can only be obtained artificially. By 2010, the first 118 elements were known, thereby completing the first seven rows of the table; however, chemical characterization is still needed for the heaviest elements to confirm that their properties match their positions. New discoveries will extend the table beyond these seven rows, though it is not yet known how many more elements are possible; moreover, theoretical calculations suggest that this unknown region will not follow the patterns of the known part of the table. Some scientific discussion also continues regarding whether some elements are correctly positioned in the table. Many alternative representations of the periodic law exist, and there is some discussion as to whether there is an optimal form of the periodic table.
Tc is maximal near 92 K (−181.2 °C) when x ≈ 0.15 and the structure is orthorhombic. Superconductivity disappears at x ≈ 0.6, where the structural transformation of YBCO occurs from orthorhombic to tetragonal.
== History == The Open Insulin Project was started in 2015 by Anthony Di Franco, himself a type 1 diabetic. He started the project in response to the unreasonably high prices of insulin in the US. The project has been housed in Counter Culture Labs, a community laboratory and makerspace in the Bay Area. Other collaborators include ReaGent, BioCurious and BioFoundry.
8% w/v Na2CO3·H2O (CAS: 5968-11-6) 1.6% w/v NaOH (CAS: 1310-73-2) 1.6% w/v Na2 tartrate (CAS: 868-18-8) (10x concentration as Reagent A in Original BCA Assay above) Sufficient NaHCO3 (CAS: 144-55-8) to adjust pH to 11.25 Micro-Reagent B (MB)
== Production == Artificial nanoparticles can be created from any solid or liquid material, including metals, dielectrics, and semiconductors. They may be internally homogeneous or heterogenous, e.g. with a core–shell structure. There are several methods for creating nanoparticles, including gas condensation, attrition, chemical precipitation, ion implantation, pyrolysis, hydrothermal synthesis, and biosynthesis.
Sources: en.wikipedia.org
It mirrors the 44-residue form of human growth hormone-releasing hormone. A hexenoyl group on the N-terminal tyrosine distinguishes it from the unmodified hormone. The change is intended to improve resistance to enzymatic breakdown.
The N-terminal modification reduces cleavage by circulating peptidases, so the peptide persists longer than native GHRH. That persistence is the main rationale for the synthetic design. Comparative half-life values in humans are reported in regulatory review documents rather than in general reference literature.
Reductions in visceral adipose tissue have been measured in controlled studies of defined populations. Whether the effect generalizes to other groups and persists after treatment stops is less clear. Longer-term outcome data remain limited.
The principal difference is a chemical cap on the N-terminal tyrosine that prevents rapid enzymatic cleavage. Native GHRH is degraded within minutes in plasma, whereas the modified peptide persists considerably longer. The amino acid backbone otherwise mirrors the natural hormone.